Palo Alto, CANCT06137157Now EnrollingIRB Ready

Netherton Syndrome Clinical Trial in Palo Alto, CA

Access cutting-edge netherton syndrome treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by Azitra Inc.

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions…

Expert Care in Palo Alto

Access netherton syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related netherton syndrome treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this netherton syndrome clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This Netherton Syndrome Study in Palo Alto

The objectives of this clinical trial are to evaluate the safety and tolerability of topically applied ATR12-351, to understand what the body does to ATR12-351, and to observe treatment benefits of the drug in approximately 12 adult patients with Netherton Syndrome (NS). ATR12-351 will be applied to skin lesions on one side of the body, while the vehicle control will be applied to similar lesion on the other side of the body twice daily for 2 weeks.

Sponsor: Azitra Inc.

Who Can Participate

Inclusion Criteria

Adults ≥18 years of age
Confirmed mutation of the serine protease inhibitor of Kazal type 5 (SPINK5) gene
Involvement of ≥20% of body surface area with skin changes consistent with Netherton syndrome

Exclusion Criteria

Use of biologic therapies, antibiotics, antihistamines, corticosteroids, retinoids, disease-modifying antirheumatic drugs (DMARDs), immunosuppressive agents, phosphodiesterase-4 (PDE4) inhibitors, topical calcineurin inhibitors, or topical Janus kinase (JAK) inhibitors
Open wounds or extensive areas of excoriation precluding identification of appropriate application sites in the Investigator's judgment
Concurrent involvement in any other clinical study/expanded access program with an investigational drug or device or has participated in a clinical study within 30 days prior to the screening visit
Residing with an immunocompromised person in the same dwelling from the baseline visit through 2 weeks after the treatment period
History of ultraviolet phototherapy within the planned treatment area 4 weeks prior to baseline

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT06137157) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Netherton Syndrome Treatment Options in Palo Alto, CA

If you're searching for netherton syndrome treatment options in Palo Alto, CA, this clinical trial (NCT06137157) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced netherton syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all netherton syndrome clinical trials near you to find additional studies recruiting in your area.

More Neuroendocrine Tumors Trials in Palo Alto, CA

See all neuroendocrine tumors clinical trials recruiting in Palo Alto — not just this study.

Browse Neuroendocrine Tumors Trials in Palo Alto →

Browse More Trials by Condition

Neuroendocrine Tumors TrialsEssential Tremor TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Palo Alto, CA